OTC - ACTIVE INGREDIENT SECTION
Active ingredients
Kalium muriaticum (Potassium chloride) 6X
KALIUM MURIATICUM 6X
- Manufacturer
- Seroyal USA | SAN'UP
- Effective date
- 2022-07-07
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 7
- Source
- full-release
- Hydrated at
- 2026-06-01 02:17:41
Label at a glance#
ProductKALIUM MURIATICUM 6X
Active ingredientPOTASSIUM CHLORIDE
Label structure12 sections
Label contents#
Full prescribing information#
OTC - PURPOSE SECTION
Uses
Helps promote and maintain healthy skin.
WARNINGS SECTION
Warnings
Do not use if you ever had an allergic reaction to this product or any of its ingredients.
Stop use and ask a doctor if symptoms persist or worsen.
If pregnant or breastfeeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a
Poison Control Center right away
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breastfeeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
OVERDOSAGE SECTION
In case of overdose, get medical help or contact a Poison Control Center right away.
OTC - STOP USE SECTION
Stop use and ask a doctor if symptoms persist or worsen.
OTHER SAFETY INFORMATION
Other information
Do not use if seal is missing or broken.
Store in a cool, dry place.
INACTIVE INGREDIENT SECTION
Inactive ingredients
Lactose monohydrate (milk), magnesium stearate, sodium carboxymethylcellulose, xylitol
DOSAGE & ADMINISTRATION SECTION
Directions
Tip bottle slightly allowing for tablets to fall into the cap.
Use cap to drop tablets into mouth and allow them to dissolve under the tongue.
Adults and adolescents (12 years and older)
Take 1 to 4 tablets, one to four times daily, or as recommended by your healthcare practitioner.
Children (under 12 years)
Take under the direction of your healthcare practitioner.
INDICATIONS & USAGE SECTION
Uses
Helps promote and maintain healthy skin.
Directions
Tip bottle slightly allowing for tablets to fall into the cap.
Use cap to drop tablets into mouth and allow them to dissolve under the tongue.
Adults and adolescents (12 years and older)
Take 1 to 4 tablets, one to four times daily, or as recommended by your healthcare practitioner.
Children (under 12 years)
Take under the direction of your healthcare practitioner.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
NDC 62106-1054-2
UNDA
tissue salt
KALIUM MURIATICUM 6X
Homeopathic Remedy
Schüessler Salt
Helps promote and maintain healthy skin.
100 Tablets
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62106-1054-2 | KALIUM MURIATICUM 6X | 100 in 1 BOTTLE, GLASS | TABLET | 100 | 7 | |
| 62106-1054-2 | KALIUM MURIATICUM 6X | 1 in 1 CARTON | TABLET | 1 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62106-1054 | KALIUM MURIATICUM 6X (POTASSIUM CHLORIDE) TABLET [SEROYAL USA] | 7 | Current NDC, Legacy NDC, 2 package rows | 20220709_22c95b6a-dd5d-476e-e054-00144ff8d46c.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | 3 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 3 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 3 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 3 | |
| XYLITOL | INACTIVE INGREDIENT | VCQ006KQ1E | 3 |
Products#
Every source-derived product name is available through these pages.
- KALIUM MURIATICUM 6X
- Potassium Chloride
- POTASSIUM CATION
- XYLITOL
- CROSCARMELLOSE SODIUM
- MAGNESIUM STEARATE
- LACTOSE MONOHYDRATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62106-1054 | 62106-1054-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| POTASSIUM CHLORIDE | 660YQ98I10 | ACTIB |
| XYLITOL | VCQ006KQ1E | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / SUBLINGUAL | 10 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | SPRAY / SUBLINGUAL | 22 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / SUBLINGUAL | 10 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / SUBLINGUAL | 505 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | TABLET / ORAL | 15.04 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | SPRAY / SUBLINGUAL | 22 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | TABLET / ORAL | 15.04 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / SUBLINGUAL | 505 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| KALIUM MURIATICUM 6X | POTASSIUM CHLORIDE | Seroyal USA | 22c95b6a-dd5d-476e-e054-00144ff8d46c | 2022-07-07 | Warnings | 62106-1054-2 62106-1054 62106105402 e33c6585-d77e-0547-e053-2a95a90ad493 22c95b6a-dd5d-476e-e054-00144ff8d46c |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.